Inflectra, a global leader in IT software lifecycle management and test automation, announced it has launched on the AWS KSA Region. This marks Inflectra's flagship platforms—SpiraPlan and Rapise—in ...

Pfizer (PFE) reported $17.56 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of ...

Pfizer is suing Johnson & Johnson, alleging that it induced US health insurers to help it block biosimilar competition to its blockbuster Remicade. Pfizer's Inflectra was the first monoclonal antibody ...

In its upcoming report, Pfizer (PFE) is predicted by Wall Street analysts to post quarterly earnings of $0.57 per share, reflecting a decline of 9.5% compared to the same period last year. Revenues ...

Medaptus, a provider of intelligent charge capture and revenue reconciliation solutions for hospitals and physician groups, today announced an agreement with athenahealth, Inc. through the company's ...

With its industry?unique, end?to?end CryoVault® rigid container platform for the freeze and thaw of critical biopharmaceuticals, and its newly introduced TepoFlex® flexible biocontainer portfolio for ...

In the global biosimilars market, the sands are shifting underfoot. It's time for all stakeholders to re-examine the present environment and re-set expectations for the future. From the creation of a ...